THC BioMed Intl Ltd. appointed Damien Reynolds as Chief Capital Markets Officer. Mr. Reynolds brings over 25 years of Global Capital markets experience including M&A, start up incubation, strategic investments and has been directly involved in raising significant venture capital. Mr. Reynolds
will be instrumental in helping the Company achieve its goal of global growth. The company welcomes Damien to the team and looks forward to building a successful international life sciences company.